Screening for Cystic Fibrosis

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Acta Paediatrica Scandinavica

• Publication date

  1987-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1651-2227.1987.tb10449.xPMID 3591288
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A comparison of the Shwachman, Chrispin-Norman and Brasfield methods for scoring of chest radiographs of patients with cystic fibrosis

  2006cited by this paper
• The systematic evaluation of the chest radiograph in cystic fibrosis

  2005cited by this paper
• Survival of patients with cystic fibrosis.

  1989cited by this paper
• Neonatal screening for cystic fibrosis.

  1986cited by this paper
• Cystic fibrosis mortality in England and Wales and in Victoria, Australia 1976-80.

  1984cited by this paper
• Diagnosis and Treatment of Cystic Fibrosis: An Update

  1984cited by this paper
• Neonatal Screening for Cystic Fibrosis: Position Paper

  1983cited by this paper
• Improved respiratory prognosis in patients with cystic fibrosis with normal fat absorption.

  1982cited by this paper
• Screening for cystic fibrosis.

  1982cited by this paper
• INCIDENCE AND SURVIVAL CURVES OF CYSTIC FIBROSIS IN SWEDEN

  1982cited by this paper
• Secretin pancreozymin stimulation test and confirmation of the diagnosis of cystic fibrosis.

  1982cited by this paper
• With commentary

  1982cited by this paper
• CYSTIC FIBROSIS IN DENMARK IN THE PERIOD 1945‐1981 EVALUATION OF CENTRALIZED TREATMENT

  1982cited by this paper
• Why we should not screen our newborns for cystic fibrosis.

  1981cited by this paper
• Screening of newborns for cystic fibrosis.

  1980cited by this paper
• Should we screen all newborns for cystic fibrosis?

  1978cited by this paper
• Screening for cystic fibrosis.

  1977cited by this paper
• [Neonatal screening for cystic fibrosis].

  1977cited by this paper
• The effect of early diagnosis and treatment in cystic fibrosis: a seven-year study of 16 sibling pairs.

  1977cited by this paper
• Classification at time of diagnosis and subsequent survival in children with cystic fibrosis.

  1977cited by this paper
• Cystic fibrosis in the Netherlands.

  1977cited by this paper
• Cystic fibrosis in the Netherlands

  1977cited by this paper
• Course of cystic fibrosis in 95 patients.

  1976cited by this paper
• Screening for cystic fibrosis.

  1973cited by this paper
• Life tables for cystic fibrosis.

  1971cited by this paper
• Survival of patients with cystic fibrosis.

  1970cited by this paper
• Studies in cystic fibrosis. Report of 130 patients diagnosed under 3 months of age over a 20-year period.

  1970cited by this paper
• A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis.

  1959cited by this paper
• Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period.

  1958cited by this paper

• Reflections on 50 Years of Cystic Fibrosis Newborn Screening Experience with Critical Perspectives, Assessment of Current Status, and Predictions for Future Improvements

  2025cites this paper
• 'We're kind of like genetic nomads': Parents' experiences of biographical disruption and uncertainty following in/conclusive results from newborn cystic fibrosis screening.

  2022cites this paper
• Framing utility: Regulatory reform and genetic tests in the USA, 1989–2000

  2020cites this paper
• Cystic Fibrosis Frequently Asked Questions Does newborn screening improve early lung function in cystic fibrosis?

  2020cites this paper
• Cascading After Peridiagnostic Cancer Genetic Testing: An Alternative to Population-Based Screening

  2020cites this paper
• Equity in genetic newborn screening

  2019cites this paper
• The cost-effectiveness of neonatal screening for cystic fibrosis: an analysis of alternative scenarios using a decision model

  2019cites this paper
• Neonatal Screening for Cystic Fibrosis: A Meta Analysis Study

  2019influential citation
• CFTR and Cystic Fibrosis: From Structure to Function

  2018cites this paper
• Carrier Screening for Cystic Fibrosis: Past, Present and Future

  2017cites this paper
• Genomic futures of prenatal screening: ethical reflection

  2016cites this paper
• Current recommendations: Screening for Mendelian disorders.

  2016cites this paper
• Several siblings with Cystic Fibrosis as a risk factor for poor outcome.

  2015cites this paper
• The evolution of blood-spot newborn screening.

  2014cites this paper
• Parents' responses to receiving sickle cell or cystic fibrosis carrier results for their child following newborn screening

  2014cites this paper
• Prenatal Screening Using Maternal Markers

  2014cites this paper
• Population-based carrier screening for cystic fibrosis: a systematic review of 23 years of research

  2013cites this paper
• When is the Use of Race/Ethnicity Appropriate in Risk Assessment Tools for Preconceptual or Antenatal Genetic Screening and How Should it be Used?

  2013cites this paper
• Cystic fibrosis carrier screening.

  2013cites this paper
• Prenatal diagnosis and preimplantation genetic control and moral questions

  2012cites this paper
• Estimating the Prevalence of Nonpaternity in Germany

  2012cites this paper
• Child-parent screening for familial hypercholesterolemia.

  2011cites this paper
• Implementation of the first worldwide quality assurance program for cystic fibrosis multiple mutation detection in population-based screening.

  2011cites this paper
• Is Neonatale Screening op Mucoviscidose aangewezen in België?

  2010cites this paper
• Original Research: Parents and Children with Cystic Fibrosis

  2010cites this paper
• Cochrane review: Newborn screening for cystic fibrosis

  2009cites this paper
• Summary of ‘Newborn screening for cystic fibrosis’, including tables of key findings and quality of included trials

  2009cites this paper
• Neonatal screening for cystic fibrosis in São Paulo State, Brazil: a pilot study.

  2009cites this paper
• Newborn screening for cystic fibrosis: A paradigm for public health genetics policy development

  2009cites this paper
• Assessing the Potential Success of Cystic Fibrosis Carrier Screening: Lessons Learned from Tay-Sachs Disease and β-Thalassemia

  2009cites this paper
• Psychosocial Aspects of Newborn Screening Programs for Cystic Fibrosis

  2008cites this paper
• Incidence of cystic fibrosis in five different states of Brazil as determined by screening of p.F508del, mutation at the CFTR gene in newborns and patients.

  2008cites this paper
• A Systematic Review of the Effects of Disclosing Carrier Results Generated Through Newborn Screening

  2008cites this paper
• Historical Background

  2008cites this paper
• Decisions About Testing and Termination of Pregnancy for Different Fetal Conditions: A Qualitative Study of European White and Pakistani Mothers of Affected Children

  2008cites this paper
• Newborn screening for cystic fibrosis: a lesson in public health disparities.

  2008cites this paper
• Fibrosis Quística: mutaciones más frecuentes en la población mundial

  2008cites this paper
• Nutritional, anthropometric and biochemical evaluation of children with cystic fibrosis

  2008cites this paper
• The Northwest Regional Newborn Screening Program

  2008cites this paper
• Genetic screening for cystic fibrosis: an overview of the science and the economics.

  2007influential citation
• Newborn screening in the Asia Pacific region

  2007cites this paper
• fibrosis on reported maternal behaviour . Effects of newborn screening of cystic

  2007cites this paper
• Molecular Genetic Analysis of a Consanguineous South Indian Family with Congenital Glaucoma: Relevance of Genetic Testing and Counseling

  2007cites this paper
• Newborn screening for cystic fibrosis.

  2007cites this paper
• Newborn screening for CF in a regional paediatric centre: the psychosocial effects of false-positive IRT results on parents.

  2007cites this paper
• Is Cystic Fibrosis Carrier Screening Cost Effective?

  2007cites this paper
• Targeted Extended Cystic Fibrosis Mutation Testing on Known and At-Risk Patients and Relatives

  2007cites this paper
• Attitudes and beliefs of pediatricians and genetic counselors regarding testing and screening for CF and G6PD: Implications for policy

  2006cites this paper
• Screening for conditions that do not meet the Wilson and Jungner criteria: The case of Duchenne muscular dystrophy

  2006cites this paper
• GPs' opinions of their role in prenatal genetic services: a cross-sectional survey.

  2006cites this paper
• Genetic screening by DNA technology: A systematic review of health economic evidence

  2006cites this paper
• How Well Does Paternity Confidence Match Actual Paternity?

  2006cites this paper
• Genetic health technology and economic evaluation

  2006cites this paper
• The cost-effectiveness of neonatal screening for Cystic Fibrosis: an analysis of alternative scenarios using a decision model

  2005influential citation
• Preconception Cystic Fibrosis Carrier Screening: Costs and Consequences

  2005cites this paper
• Cost-effectiveness of a school-based Tay-Sachs and cystic fibrosis genetic carrier screening program

  2005cites this paper
• A methodological review of how heterogeneity has been examined in systematic reviews of diagnostic test accuracy.

  2005cites this paper
• Diagnosis and management of cystic fibrosis

  2005cites this paper
• Putting Genetics to Use

  2005cites this paper
• Review of outcomes of neonatal screening for cystic fibrosis versus non-screening in Europe.

  2005cites this paper
• Newborn screening for congenital heart defects: a systematic review and cost-effectiveness analysis.

  2005cites this paper
• Psychosocial aspects of genetic screening of pregnant women and newborns: a systematic review.

  2004cites this paper
• Raising the profile of genetics in primary care

  2004cites this paper
• Cystic fibrosis in Estonia

  2004cites this paper
• Principles of screening

  2004cites this paper
• Disclosing to parents newborn carrier status identified by routine blood spot screening.

  2004cites this paper
• THE VALUE OF SWEAT CHLORIDE TEST IN THE DIAGNOSIS OF CYSTIC FIBROSIS AMONG JORDANIAN CHILDREN

  2004cites this paper
• Generalised prenatal screening for cystic fibrosis Membership of the Working Group

  2004cites this paper
• Psychosocial issues in newborn screening for cystic fibrosis.

  2003cites this paper
• Comparing the clinical evolution of cystic fibrosis screened neonatally to that of cystic fibrosis diagnosed from clinical symptoms: A 10‐year retrospective study in a French region (Brittany)

  2003cites this paper
• Cascade carrier-testing in cystic fibrosis.

  2003cites this paper
• Ethnicity and the Politics of the New Genetics: Principles and Engagement

  2003cites this paper
• Population genetic screening programmes: principles, techniques, practices, and policies

  2003cites this paper
• Population screening for cystic fibrosis: Knowledge and emotional consequences 18 months later

  2003influential citation
• Neonatal biochemical screening for disease.

  2002cites this paper
• Evaluation of cystic fibrosis carrier screening programs according to genetic screening criteria

  2002cites this paper
• Shortage of vaccines: USA, Europe, who next?

  2002cites this paper
• Disclosing carrier status to parents following newborn screening

  2002cites this paper
• Molecular diagnosis of cystic fibrosis

  2002cites this paper
• Outcome of Burkholderia cepacia colonisation in an adult cystic fibrosis centre

  2002cites this paper
• Personal experiences of cystic fibrosis (CF) carrier couples prospectively identified in CF families.

  2002cites this paper
• Reviewing local screening policies – a worthwhile exercise?

  2002cites this paper
• Cystic fibrosis screening in newborns: results from existing programs

  2001cites this paper
• [Neonatal screening for cystic fibrosis].

  2001cites this paper
• Extending Antenatal Screening in the UK to Include Common Monogenic Disorders

  2001cites this paper
• Cystic fibrosis‐related deaths in infancy and the effect of newborn screening

  2001cites this paper
• Influence of neonatal screening and centralized treatment on long-term clinical outcome and survival of CF patients.

  2001cites this paper
• [Does neonatal screening of cystic fibrosis affect outcome? Comparative study of two cohorts in Britanny and Loire-Atlantique with follow-up after ten years].

  2000cites this paper
• Le dépistage néonatal systématique améliore-t-il le pronostic de la mucoviscidose ?Étude comparative de deux cohortes en Bretagne et en Loire-Atlantique avec un recul de dix ans

  2000cites this paper
• Screening gamete donors for cystic fibrosis status

  2000cites this paper
• Development of an Antenatal Screening Programme for Congenital Abnormalities in a South Wales District: Lessons Learnt for Clinical Governance

  2000cites this paper
• Advances in Genetics: Issues for US Racial and Ethnic Minorities: An Asian American and Pacific Islander Perspective

  1999cites this paper
• Neonatal screening for cystic fibrosis: present and future

  1999cites this paper
• Screening for cystic fibrosis and its evaluation.

  1998cites this paper
• Establishing criteria for a carrier detection panel: lessons from the Ashkenazi Jewish model.

  1998cites this paper
• Screening for Cystic Fibrosis

  1998cites this paper
• PCR-based screening for cystic fibrosis carrier mutations in an ethnically diverse pregnant population.

  1997cites this paper
• Pilot study of the acceptability of cystic fibrosis carrier testing during routine antenatal consultations in general practice.

  1996cites this paper
• Cystic fibrosis carrier population screening in the primary care setting.

  1996cites this paper
• Long term prognosis of patients with cystic fibrosis in relation to early detection by neonatal screening and treatment in a cystic fibrosis centre.

  1995cites this paper